New Zealand markets closed

FibroGen, Inc. (FGEN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1.0400+0.0200 (+1.96%)
At close: 04:00PM EDT
1.0101 -0.03 (-2.88%)
After hours: 05:18PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 102.72M
Enterprise value 19.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.68
Price/book (mrq)N/A
Enterprise value/revenue 0.13
Enterprise value/EBITDA -0.08

Trading information

Stock price history

Beta (5Y monthly) 0.74
52-week change 3-93.70%
S&P500 52-week change 322.36%
52-week high 319.4700
52-week low 30.3330
50-day moving average 31.7997
200-day moving average 31.2530

Share statistics

Avg vol (3-month) 32.77M
Avg vol (10-day) 31.2M
Shares outstanding 598.77M
Implied shares outstanding 698.77M
Float 887.97M
% held by insiders 10.92%
% held by institutions 169.31%
Shares short (15 Apr 2024) 45.43M
Short ratio (15 Apr 2024) 42.72
Short % of float (15 Apr 2024) 47.23%
Short % of shares outstanding (15 Apr 2024) 45.50%
Shares short (prior month 15 Mar 2024) 45.53M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -192.37%
Operating margin (ttm)-381.26%

Management effectiveness

Return on assets (ttm)-35.54%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)147.75M
Revenue per share (ttm)1.52
Quarterly revenue growth (yoy)-21.00%
Gross profit (ttm)N/A
EBITDA -283.92M
Net income avi to common (ttm)-284.23M
Diluted EPS (ttm)-2.9200
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)235.59M
Total cash per share (mrq)2.38
Total debt (mrq)170.46M
Total debt/equity (mrq)N/A
Current ratio (mrq)1.52
Book value per share (mrq)-2.07

Cash flow statement

Operating cash flow (ttm)-315.02M
Levered free cash flow (ttm)-220.02M